Literature DB >> 23983333

Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma.

Qizhe Sun1, Wenli Ma, Yuan Gao, Wenling Zheng, Bao Zhang, Yifei Peng.   

Abstract

Compound Kushen Injection (CKI) is Sophora Flavescens and Heterosmilacis Japonicae extract. Meta-analysis confirmed that CKI plus transcatheter arterial chemoembolization (TACE) is more superior to TACE alone for unresectable hepatocellular carcinoma (UHCC) patients.

Entities:  

Keywords:  Compound Kushen Injection; TACE; Transcatheter arterial chemoembolization; hepatocellular carcinoma

Mesh：

Substances：

Year:  2011        PMID： 23983333      PMCID： PMC3746636          DOI： 10.4314/ajtcam.v9i2.1

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN： 2505-0044


  9 in total

Review 1.  Prognostic prediction and treatment strategy in hepatocellular carcinoma.

Authors:  Jordi Bruix; Josep M Llovet
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

2.  Evaluation of response: new and standard criteria.

Authors:  P Therasse
Journal:  Ann Oncol       Date:  2002       Impact factor: 32.976

3.  [Clinicel study on treatment of advanced primary liver cancer by Yanshu injection combining with chemotherapy].

Authors:  Cheng-Nong Guan; Liang-Zhen Cai; Li-Qun Yue; Ying Zhang
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2006-03

4.  Chemoembolization for hepatocellular carcinoma.

Authors:  A P Venook; R J Stagg; B J Lewis; J L Chase; E J Ring; T P Maroney; D C Hohn
Journal:  J Clin Oncol       Date:  1990-06       Impact factor: 44.544

5.  Evaluation of patients with advanced cancer using the Karnofsky performance status.

Authors:  J W Yates; B Chalmer; F P McKegney
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

6.  Reporting results of cancer treatment.

Authors:  A B Miller; B Hoogstraten; M Staquet; A Winkler
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

7.  Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors.

Authors:  Alain Roche; Baragur V Girish; Thierry de Baère; Eric Baudin; Valérie Boige; Dominique Elias; Philippe Lasser; Martin Schlumberger; Michel Ducreux
Journal:  Eur Radiol       Date:  2002-07-23       Impact factor: 5.315

8.  Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.

Authors:  J W Chung; J H Park; J K Han; B I Choi; M C Han; H S Lee; C Y Kim
Journal:  Radiology       Date:  1996-01       Impact factor: 11.105

Review 9.  Chemoembolization in the management of liver tumors.

Authors:  Keith Stuart
Journal:  Oncologist       Date:  2003
  9 in total
  18 in total

1.  Synthesis, Biological Evaluation, and Autophagy Mechanism of 12N-Substituted Sophoridinamines as Novel Anticancer Agents.

Authors:  Chongwen Bi; Na Zhang; Peng Yang; Cheng Ye; Yanxiang Wang; Tianyun Fan; Rongguang Shao; Hongbin Deng; Danqing Song
Journal:  ACS Med Chem Lett       Date:  2017-01-05       Impact factor: 4.345

2.  Oxymatrine induces apoptosis and inhibits invasion in Gallbladder carcinoma via PTEN/PI3K/AKT pathway.

Authors:  Liqiang Qian; Xiaqin Li; Penghui Ye; Gang Wang; Wei Dai; Yan Liu; Quangen Gao; Genhai Shen
Journal:  Cytotechnology       Date:  2017-11-23       Impact factor: 2.058

3.  Synthesis and biological evaluation of sophoridinol derivatives as a novel family of potential anticancer agents.

Authors:  Chongwen Bi; Caixia Zhang; Yinghong Li; Sheng Tang; Shenggang Wang; Rongguang Shao; Haigen Fu; Feng Su; Danqing Song
Journal:  ACS Med Chem Lett       Date:  2014-09-22       Impact factor: 4.345

Review 4.  Anti-tumor activities of active ingredients in Compound Kushen Injection.

Authors:  Wei Wang; Rong-li You; Wen-jie Qin; Li-na Hai; Ming-jing Fang; Guo-hua Huang; Rui-xia Kang; Ming-hua Li; Yu-feng Qiao; Jian-wei Li; An-ping Li
Journal:  Acta Pharmacol Sin       Date:  2015-05-18       Impact factor: 6.150

Review 5.  Anti-tumor activities of matrine and oxymatrine: literature review.

Authors:  Yan Liu; Yang Xu; Weidan Ji; Xiaoya Li; Bin Sun; Quangen Gao; Changqing Su
Journal:  Tumour Biol       Date:  2014-02-14

6.  Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways.

Authors:  Zhizheng Zhao; Huiting Fan; Tim Higgins; Jia Qi; Diana Haines; Anna Trivett; Joost J Oppenheim; Hou Wei; Jie Li; Hongsheng Lin; O M Zack Howard
Journal:  Cancer Lett       Date:  2014-09-19       Impact factor: 8.679

7.  Compound Radix Sophorae Flavescentis exerts antitumor effects by inhibiting the proliferation and inducing the apoptosis of esophageal carcinoma TE-8 cells.

Authors:  Xiaoyu Yang; Weimei Cai; Qinghui Yang; Zhihong Lu; Jinsong Li; Jian Yu
Journal:  Oncol Lett       Date:  2015-08-13       Impact factor: 2.967

8.  Management of hepatocellular carcinoma: an overview of major findings from meta-analyses.

Authors:  Xingshun Qi; Yan Zhao; Hongyu Li; Xiaozhong Guo; Guohong Han
Journal:  Oncotarget       Date:  2016-06-07

Review 9.  The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis.

Authors:  Xiao Ma; Rui-Sheng Li; Jian Wang; Yin-Qiu Huang; Peng-Yan Li; Ji Wang; Hai-Bin Su; Rui-Lin Wang; Ya-Ming Zhang; Hong-Hong Liu; Cong-En Zhang; Zhi-Jie Ma; Jia-Bo Wang; Yan-Ling Zhao; Xiao-He Xiao
Journal:  Front Pharmacol       Date:  2016-03-31       Impact factor: 5.810

Review 10.  Efficacy of Compound Kushen Injection in Relieving Cancer-Related Pain: A Systematic Review and Meta-Analysis.

Authors:  Yu-Ming Guo; Yi-Xue Huang; Hong-Hui Shen; Xiu-Xiu Sang; Xiao Ma; Yan-Ling Zhao; Xiao-He Xiao
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-04       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.